Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07233447

Prevalence of H. Pylori in Stomach Cancers in the West Indies

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Centre Hospitalier Universitaire de la Guadeloupe · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The incidence and mortality of stomach cancer are higher in the French West Indies than in mainland France. The prevalence of H. pylori infection associated with this cancer remains unknown in these populations. The main objective of the study is to estimate the prevalence of H. Pylori detected by immunohistochemistry in patients newly diagnosed with cancer.

Detailed description

Stomach cancer is the 4th most common cancer site in the world and the 3rd cause of mortality. It is associated with infection by the Helicobacter Pylori bacterium, which colonizes the gastric mucosa in 80% of cases. The decrease of the prevalence of H. pylori infection in developed countries with the advent of antibiotic treatments is responsible for the decrease in the incidence of stomach cancer. But in the French West Indies, stomach cancer remains in excess incidence and mortality compared to France. The prevalence of H. pylori infection remains unknown, both in general population and in patients with stomach cancer. Eating habits combining high consumption of salt, meat and smoked fish could partly explain these high incidences. Furthermore, recent observations suggest that environmental risk factors (pesticides pollution) could also be involved in the occurrence of this cancer. Estimating the prevalence of H. pylori in stomach cancers will improve the epidemiological knowledge of this cancer with high incidence rates and prevention measures.

Conditions

Timeline

Start date
2025-02-24
Primary completion
2027-02-24
Completion
2027-02-24
First posted
2025-11-18
Last updated
2025-11-18

Locations

2 sites across 1 country: Guadeloupe

Source: ClinicalTrials.gov record NCT07233447. Inclusion in this directory is not an endorsement.